Capital International LTD Ultragenyx Pharmaceutical Inc. Transaction History

Capital International LTD

$2.23 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $116,643 - $193,062	2,919 Added 10.58%	30,511 $1.26 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $69,616 - $129,808	-1,520 Reduced 5.22%	27,592 $1.65 Million
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $2.37 Million - $3.22 Million	-38,100 Reduced 56.69%	29,112 $2.11 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $145,798 - $173,787	1,978 Added 3.03%	67,212 $5.65 Million
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $65,764 - $86,425	-844 Reduced 1.28%	65,234 $5.88 Million
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $31,344 - $39,341	-340 Reduced 0.51%	66,078 $6.3 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $1.42 Million - $2.23 Million	-13,324 Reduced 16.71%	66,418 $7.56 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $85,750 - $180,228	1,016 Added 1.29%	79,742 $11 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $1.31 Million - $1.61 Million	17,900 Added 29.43%	78,726 $6.47 Million
Q4 2019 Feb 18, 2020	BUY	$36.08 - $45.83 $646,012 - $820,586	17,905 Added 41.72%	60,826 $2.6 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $935,042 - $1.39 Million	22,001 Added 105.17%	42,921 $1.84 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $82,065 - $111,093	1,494 Added 7.69%	20,920 $1.33 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $112,672 - $196,011	2,826 Added 17.02%	19,426 $1.35 Million
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $2.18 Million - $2.74 Million	-30,357 Reduced 64.65%	16,600 $1.27 Million
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $664,998 - $1.17 Million	-13,700 Reduced 22.59%	46,957 $3.61 Million
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $61,042 - $80,582	-1,377 Reduced 2.22%	60,657 $3.09 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $8.9 Million - $11.7 Million	-204,466 Reduced 76.72%	62,034 $2.88 Million
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $13.3 Million - $17.7 Million	266,500	266,500 $14.2 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$428 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$241 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$220 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$179 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$132 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account